Aktuelles über Passiflora incarnata

Zusammenfassung

Die Vielzahl wissenschaftlicher Publikationen, die in den letzten Jahren über Passionsblumenkraut und daraus hergestellte Extrakte erschienen sind, zeigt die anhaltende Bedeutung dieser Arzneipflanze. Neben zahlreichen pharmakologischen Untersuchungen - besonders einer indischen Forschergruppe - liegen auch erste klinische Studien mit Monopräparaten aus Passiflorae herba vor. Aus einer Reihe von In-vivo-Studien lassen sich dosisabhängige anxiolytische Effekte von Passiflora-Extrakten ableiten. In den ersten klinischen Studien an Patienten mit Angststörungen konnten mit Passiflora- Monopräparaten sehr gute Ergebnisse erzielt werden.

Summary

The number of papers dealing with Passionflower herb, which have been published during the last years, shows the continuous importance of this medicinal plant. Besides numerous pharmacological studies - mainly from a research group from India - first clinical studies with monopreparations of Passiflorae herba have been performed. Several pharmacological studies point to a dose-dependent anxiolytic activity of Passionflower extracts. In first clinical studies in patients with general anxiety disorders, who received Passionflower monopreparations, very good results were achieved.

Schlüsselwörter

Passionsblume - Passiflora incarnata L. - Inhaltsstoffe - Pharmakologie - klinische Studien

Key words

Passionflower - Passiflora incarnata L. - chemical constituents - pharmacological investigations - clinical studies

Literatur

• 1 Akhondzadeh S, Kashani L, Mobaseri M. et al. . Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.  J Clin Pharm Therap. 2001;  26 369-373
• 2 Akhondzadeh S, Naghavi HR, Vazirian M. et al. . Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.  J Clin Pharm Therap. 2001;  26 363-367
• 3 Ansseau M. Evaluation des paramètres d'activite de gélules d'extrait sec de Passiflore selon un modèle »en etoiles«.  J Pharm Belg. 2004;  59 97-99
• 4 Aoyagi N, Kimura R, Murata T. Studies on Passiflora incarnata dry extract. I. Isolation of maltol and pharmacological action of maltol and ethyl maltol.  Chem Pharm Bull. 1974;  22 1008-1013
• 5 Brasseur T, Angenot L. Contribution à l'étude pharmacognostique de la Passiflore.  J Pharm Belg. 1984;  39 15-22
• 6 Buchbauer G, Jirovetz L. Volatile constituents of the essential oil of Passiflora incarnata L.  J Essent Oil Res. 1992;  4 329-34
• 7 Burkard W, Kopp B, Krenn L. et al. . Receptor binding studies in the CNS with extracts of Passiflora incarnata.  Pharm Pharmacol Lett. 1997;  7 25-26
• 8 Capasso A, Sorrentino L. Pharmacological studies on the sedative and hypnotic effect of Kava kava and Passiflora extracts combination.  Phytomedicine. 2005;  12 39-45
• 9 Dhawan K, Dhawan S, Chabra S. Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety from Passiflora incarnata L.: A not-habit forming anxiolytic.  J Pharm Pharmaceut Sci. 2003;  6 215-222
• 10 Dhawan K, Dhawan S, Sharma A. Passiflora: a review update.  J Ethnopharmacol. 2004;  94 1-23
• 11 Dhawan K, Kumar S, Sharma A. Anxiolytic activity of aerial and underground parts of Passiflora incarnata.  Fitoterapia. 2001;  72 922-926
• 12 Dhawan K, Kumar S, Sharma A. Anti-anxiety studies on extracts of Passiflora incarnata L.  J Ethnopharmacol. 2001;  78 165-170
• 13 Dhawan K, Kumar S, Sharma A. Comparative biological activity study on Passiflora incarnata and P. edulis.  Fitoterapia. 2001;  72 698-702
• 14 Dhawan K, Kumar S, Sharma A. Beneficial effects of chrysin and benzoflavone on virility in 2-year-old male rats.  J Med Food. 2002;  5 43-48
• 15 Dhawan K, Kumar S, Sharma A. Nicotine reversal effects of the benzoflavone moiety from Passiflora incarnata L. in mice.  Addiction Biology. 2002;  7 435-441
• 16 Dhawan K, Kumar S, Sharma A. Restoration of chronic delta9-THC-induced decline in sexuality in male rats by a novel benzoflavone moiety from Passiflora incarnata L.  BJP. 2002;  138 117-120
• 17 Dhawan K, Kumar S, Sharma A. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata L. in mice: a possible therapy for cannabinoid addiction.  J Pharm Pharmacol. 2002;  54 875-881
• 18 Dhawan K, Kumar S, Sharma A. Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety from Passiflora incarnata L. in mice.  J Ethnopharmacol. 2002;  81 239-244
• 19 Dhawan K, Kumar S, Sharma A. Comparative anxiolytic activity profile of various preparations of Passiflora incarnata L.: A comment on medicinal plants' standardization.  J Alternat Complement Med. 2002;  8 283-291
• 20 Dhawan K, Kumar S, Sharma A. Antiasthmatic activity of the methanol extract of leaves of Passiflora incarnata L.  Phytother Res. 2003;  17 821-822
• 21 Dhawan K, Kumar S, Sharma A. Aphrodisiac activity of methanol extract of leaves of Passiflora incarnata L. in mice.  Phytother Res. 2003;  17 401-403
• 22 Dhawan K, Sharma A. Antitussive activity of methanol extract of Passiflora incarnata L. leaves.  Fitoterapia. 2002;  73 397-399
• 23 Dhawan K, Sharma A. Prevention of chronic alcohol and nicotine-induced azospermia, sterility and decreased libido, by a novel tri-substituted benzoflavone moiety from Passiflora incarnata L. in healthy male rats.  Life Sciences. 2002;  71 3059-3069
• 24 ESCOP Monographs. 2nd Edition. European Scientific Cooperative on Phytotherapy; Stuttgart, New York: Thieme 2003: 359-364
• 25 Kimura R, Matsui S, Ito S, Aimoto T, Murata T. Central depressant effects of maltol analogs in mice.  Chem Pharm Bull. 1980;  28 2570-2579
• 26 Kommission E des BGA .Monographie Passiflorae herba. BAnz Nr. 223 v. 30.11.1985 und Nr. 50. 1990
• 27 Krenn L. Die Passionsblume (Passiflora incarnata L.) - ein bewährtes pflanzliches Sedativum.  Wien Med Wochenschr. 2002;  152 404-406
• 28 Löhdefink J, Kating H. Zur Frage des Vorkommens von Harmanalkaloiden in Passiflora-Arten.  Planta Med. 1974;  25 101-104
• 29 Lutomski J, Segiet E, Szpunar K, Grisse K. Die Bedeutung der Passionsblume in der Heilkunde.  Pharmazie in unserer Zeit. 1981;  10 45-49
• 30 Meier B. Passiflorae herba - pharmazeutische Qualität.  Z Phytotherapie. 1995;  16 90-99
• 31 Ministère des Affaires Sociales et de l'Emploide la France. . Spécialités Pharmaceutiques à Base de Plantes, Bulletin Officiel No 86/20 bis.  Übersetzung Pharm Ind. 1987;  49 1264-1274
• 32 Rahman K, Krenn L, Kopp B. et al. . Isoscoparin-2„-O-glucoside from Passiflora incarnata.  Phytochemistry. 1997;  45 1093-1094
• 33 Rehwald A, Meier B, Sticher O. Qualitative and quantitative reversed-phase high-performance liquid chromatography of flavonoids in Passiflora incarnata L.  Pharm Acta Helv. 1994;  69 153-158
• 34 Rehwald A, Sticher O, Meier B. Trace analysis of harman alkaloids in Passiflora incarnata by reversed-phase high performance liquid chromatography.  Phytochem Analysis. 1995;  6 96-100
• 35 Shinomiya K, Inoue T, Utsu Y. et al. . Hypnotic activities of Chamomile and Passiflora extracts in sleep-disturbed rats.  Biol Pharm Bull. 2005;  28 808-810
• 36 Simmen U, Burkard W, Berger K, Schaffner W, Lundstrom K. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system.  J Receptor Signal Transduct Res. 1999;  19 59-74
• 37 Spencer KC, Seigler DS. Gynocardin from Passiflora.  Planta Med. 1984;  50 356-357
• 38 Soulimani R, Younos C, Jarmouni S. et al. . Behavioural effects of Passiflora incarnata L. and its indole alkaloid and flavonoid derivatives and maltol in the mouse.  J Ethnopharmacol. 1997;  57 11-20
• 39 Tsuchiya H, Hayashi H, Sato M. et al. . Quantitative analysis of all types of β-carboline alkaloids in medicinal plants and dried edible plants by high perfomance liquid chromatography with selective fluorometric detection.  Phytochem Anal. 1999;  10 247-253
• 40 Tsuchiya H, Shimizu H, Iinuma M. Beta-carboline alkaloids in crude drugs.  Chem Pharm Bull. 1999;  47 440-443
• 41 Weischer ML, Okpanyi SN. Pharmakologie eines pflanzlichen Schlafmittels.  Z Phytotherapie. 1994;  15 257-62